1-7 of 7
Nic J.G.M. Veeger, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study

Berdien Oortgiesen, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Robby Kibbelaar, MD PhD, Huib Storm, PhD, Sjoerd Hovenga, MDPhD, Bas P Van Rees, MD PhD, Gerhard Woolthuis, MD, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2136.
https://doi.org/10.1182/blood.V124.21.2136.2136
Published: 2014
Journal Articles

Clinical Outcome After Occurrence Of Vitamin K-Antagonist Related Major Bleeding Complication: A Two-Year Observational Follow-Up Study

Nakisa Khorsand, Pharm D, Reinier M van Hest, Pharm D, PhD, Shakiba Zahedin Labbaf, MSc, Paula Ypma, MD, Helga W Vermaas, MD, Nic J.G.M. Veeger, PhD, Karina Meijer, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2382.
https://doi.org/10.1182/blood.V122.21.2382.2382
Published: 2013
Journal Articles

A Cohort Study Of 15,912 Patients On The Long-Term Quality Of Vka Therapy After Extreme Overanticoagulation

Hilde A.M. Kooistra, MD, Nakisa Khorsand, PharmD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Margriet Piersma, MD, Karina Meijer, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2384.
https://doi.org/10.1182/blood.V122.21.2384.2384
Published: 2013
Journal Articles

A Systematic Review On Different Prothrombin Complex Concentrate Strategies To Reverse Vitamin K Antagonist Therapy

Nakisa Khorsand, Pharm D, Hilde A.M. Kooistra, MD, Reinier M. van Hest, Pharm D, PhD, Nic J.G.M. Veeger, PhD, Karina Meijer, MD PhD
Journal: Blood
Blood (2013) 122 (21): 3639.
https://doi.org/10.1182/blood.V122.21.3639.3639
Published: 2013
Journal Articles

Change in Body-Mass-Index and Persisting Symptoms After Pulmonary Embolism

Anja B.U. Mäkelburg, MD, Elke S. Hoendermis, MD PhD, Nic J.G.M. Veeger, PhD, J.C. Kluin-Nelemans, Karina Meijer, MD PhD
Journal: Blood
Blood (2012) 120 (21): 3389.
https://doi.org/10.1182/blood.V120.21.3389.3389
Published: 2012
Journal Articles

Prognostic Importance of Comorbidity in a Population-Based Analysis of Patients with Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP

André Wieringa, PharmD, Eric N. van Roon, PharmD, PhD, Peter Joosten, MD, Tim Beerden, B.Sc, Huib Storm, PhD, Robby Kibbelaar, MD, PhD, Hanneke C. Kluin-Nelemans, Nic J.G.M. Veeger, PhD, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3656.
https://doi.org/10.1182/blood.V120.21.3656.3656
Published: 2012
Journal Articles

A Significant Better Two Year Survival in the Very Elderly Patients with a Diffuse Large B-Cell Lymphoma (DLBCL) Who Did Complete Standard Therapy: A Population-Based Cohort Study On Treatment, Toxicity and Outcome.

Karin Boslooper, Peter Joosten, MD, Nic J.G.M. Veeger, PhD, Robby Kibbelaar, MD, PhD, Eric van Roon, Sjoerd Hovenga, Gerhard Woolthuis, MD, Hanneke C. Kluin-Nelemans, Mels Hoogendoorn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2642.
https://doi.org/10.1182/blood.V120.21.2642.2642
Published: 2012